No Data
Zhejiang Tianyu Pharmaceutical (300702.SZ): Metformin and Ertugliflozin tablets have been approved.
On December 23, Gelonghui reported that Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical Co., Ltd., recently received the drug registration certificates approved and issued by the National Medical Products Administration for Metformin Ertugliflozin Tablets (Ⅴ) and Metformin Ertugliflozin Tablets (Ⅵ). Metformin Ertugliflozin Tablets are blood glucose-lowering medications. This product, in conjunction with dietary control and exercise, is suitable for adult patients with type 2 diabetes who are receiving treatment with Ertugliflozin and Metformin hydrochloride to improve glycemic control in these patients.
Zhejiang Tianyu Pharmaceutical (300702.SZ) subsidiary products are proposed to be selected for the tenth batch of national pharmaceutical centralized procurement.
zhejiang tianyu pharmaceutical (300702.SZ) announcement, the company's wholly-owned subsidiary zhejiang nuode pharmaceutical co., ltd. (referred to as "nuode...
TF Securities Starts Zhejiang Tianyu Pharmaceutical at Buy With 22.83 Yuan Price Target
Insiders Were the Key Beneficiaries as Zhejiang Tianyu Pharmaceutical Co., Ltd.'s (SZSE:300702) Market Cap Rises to CN¥6.3b
gf sec: The upstream prices of penicillin and cephalosporins are fluctuating at a high level, while the active pharmaceutical ingredient is finding a bottom and stabilizing.
According to the data from the National Bureau of Statistics, in September 2024, the month-on-month PPI value of chemical drug active pharmaceutical ingredient manufacturing was 97.10, an increase of 2.0 compared to the previous month, and an increase of 1.63 from the average of 95.47 in the first half of 2024. Since the year 2023, when the month-on-month PPI of active pharmaceutical ingredient manufacturing fell below 100 for the whole year, the recent PPI value has been in an increasing state, indicating that the overall price of active pharmaceutical ingredients is in a phase of slight bottoming and recovery.
Zhejiang Tianyu Pharmaceutical Co., Ltd. (SZSE:300702) Looks Inexpensive But Perhaps Not Attractive Enough
Further Weakness as Zhejiang Tianyu Pharmaceutical (SZSE:300702) Drops 11% This Week, Taking Three-year Losses to 64%
No Data
